Co-Authors
AuthorsNo. of Publications
kwong, dlw 82
lee, vhf 81
leung, tw 48
chan, wlw 29
choi, cw 29
so, th 23
lee, wma 22
chan, sy 20
khong, pl 16
tong, cc 16
lau, ks 13
law, syk 13
sze, ckh 13
choy, ts 11
lee, awm 11
ho, pyp 10
ko, jmy 10
lung, ml 10
ng, wt 10
chiang, cl 9
lai, v 9
luk, my 9
wong, ls 9
chan, sk 8
lam, tc 8
sze, hck 8
chiu, whk 7
dai, w 7
ng, cy 7
vardhanabhuti, v 7
ho, ppy 6
leung, dkc 6
liu, rky 6
ngan, kcr 6
wong, yhi 6
chan, q 5
chan, wl 5
fang, wj 5
law, tt 5
li, js 5
ng, scy 5
yuen, kk 5
chan, as 4
chan, ft 4
chen, x 4
choi, hcw 4
choi, ssa 4
kwan, ck 4
law, s 4
lee, v 4
leong, ml 4
leung, dk 4
li, ws 4
li, y 4
tung, s 4
yau, cc 4
yau, s 4
chan, d 3
chan, kc 3
chan, kkd 3
chan, wwl 3
chen, zj 3
cheng, a 3
huang, b 3
law, btt 3
lee, vh 3
li, x 3
lo, awi 3
ng, hy 3
ng, s 3
ngan, rkc 3
shek, twh 3
shek, wh 3
tsang, jwh 3
wong, c 3
xu, zy 3
yang, l 3
zheng, ss 3
an, h 2
au, kh 2
chan, asy 2
chan, ckc 2
chan, kk 2
chan, kw 2
chan, s 2
chan, yw 2
chau, i 2
chen, f 2
chen, m 2
cheung, akl 2
choi, h 2
chu, km 2
chu, s 2
clevers, h 2
cui, y 2
davidson, m 2
guan, x 2
guo, c 2
ho, gcl 2
ho, i 2
ho, py 2
ho, rsl 2
hu, y 2
huang, j 2
huse, v 2
jia, y 2
jing, hm 2
kim, tw 2
kwong, d 2
lai, yc 2
lang, hhb 2
law, lya 2
lee, ch 2
lee, kc 2
lee, sf 2
leung, rcy 2
leung, sy 2
liu, j 2
liu, ky 2
lui, yh 2
mak, tw 2
ng, sc 2
ngan, rkc 2
o'sullivan, b 2
pang, hmh 2
qin, y 2
siu, hc 2
siu, wks 2
sun, l 2
tam, fk 2
tong, dkh 2
tong, khd 2
tsang, kc 2
tsui, wy 2
wong, i 2
wong, iyh 2
wong, kp 2
wong, wy 2
wu, s 2
yan, hhn 2
yau, tcc 2
yeo, w 2
yue, sks 2
zhang, f 2
zheng, h 2
ahn, jb 1
au, gkh 1
au, j 1
bang, y-j 1
bartfeld, s 1
bartolmeo, md 1
bei, jx 1
bello, m 1
bendell, j 1
caglevic, c 1
cao, my 1
chan, asy 1
chan, b 1
chan, by 1
chan, dvk 1
chan, f 1
chan, fsy 1
chan, kch 1
chan, kkl 1
chan, kw 1
chan, ky 1
chan, mcm 1
chan, mkh 1
chan, ol 1
chan, osh 1
chan, sya 1
chan, w 1
chan, wh 1
chang, at 1
chang, ckc 1
chang, tya 1
chao, yk 1
charoentum, c 1
chau, sc 1
chen, lt 1
chen, w 1
chen, y 1
chen, z 1
cheng, al 1
cheng, hw 1
cheng, jch 1
cheng, swp 1
cheng, t 1
cheng, tkc 1
cheung, any 1
cheung, b 1
cheung, g 1
cheung, mff 1
cheung, skt 1
cheung, tc 1
cheung, yt 1
chiang, aks 1
chiu, jwy 1
chiu, k 1
chiu, kwh 1
chiu, wyj 1
choi, hc 1
choi, hh 1
chow, d 1
chow, hc 1
chow, z 1
choy, tim shing 1
chung, hc 1
chung, hp 1
chung, lp 1
chung, lp 1
ciardiello, f 1
co, thm 1
de lima lopes jr, g 1
deng, m 1
du, r 1
eng, c 1
eyck, bm 1
fan, cym 1
fan, x 1
flynn, b 1
flynn, bt 1
fong, dyt 1
fong, hch 1
fong, hl 1
foo, dcc 1
fornaro, l 1
fu, cc 1
fu, j 1
fu, mc 1
fuchs, cs 1
goekkurt, e 1
han, l 1
han, y 1
ho, d 1
ho, g 1
ho, gf 1
ho, jwk 1
ho, p 1
ho, pp 1
ho, s 1
ho, skd 1
ho, w 1
ho, wkh 1
hopkins, ki 1
hou, mo 1
huang, c 1
hui, ep 1
hui, hs 1
hung, kn 1
hung, tm 1
ip, w 1
ip, wct 1
jiang, h 1
jiang, y 1
jin, jy 1
jing, h 1
kan, pqr 1
kang, sp 1
keynote-061 investigators 1
kohne, ch 1
kong, fm(s) 1
kong, fms 1
kong, fp 1
kong, hl 1
kwok, cld 1
kwok, ctt 1
kwok, h 1
kwok, lh 1
kwok, rcc 1
lam, ccs 1
lam, csc 1
lam, cw 1
lam, cw 1
lam, e 1
lam, eym 1
lam, k 1
lam, kc 1
lam, km 1
lam, ko 1
lam, pui mei 1
lam, sy 1
lam, th 1
lam, tw 1
lam, v 1
largarde, sm 1
lau, j 1
law, al 1
law, b 1
law, bt 1
law, ck 1
law, wl 1
lee, as 1
lee, aw 1
lee, b 1
lee, cc 1
lee, ccy 1
lee, eyp 1
lee, fas 1
lee, fk 1
lee, j 1
lee, vwy 1
lee, wy 1
lei, cl 1
lei, lc 1
leong, mml 1
leung, cy 1
leung, d 1
leung, dennis kc 1
leung, dks 1
leung, hc 1
leung, kh 1
leung, to wai 1
li, cw 1
li, j 1
li, jyk 1
li, l 1
li, ss 1
li, ym 1
li, z 1
lin, rcw 1
lin, x 1
liu, f 1
liu, r 1
liu, ts 1
lo, aw 1
lo, cy 1
lo, sh 1
loong, hhf 1
lyu, z 1
ma, b 1
ma, esk 1
ma, sky 1
ma, t 1
man, hy 1
mandala, m 1
mansoor, w 1
mayo, c 1
mcdermott, rs 1
mo, kf 1
muro, k 1
ng, awy 1
ng, l 1
ng, ty 1
ng, wt 1
ngan, kc 1
nicholls, jm 1
ning, l 1
ohtsu, a 1
olesinski, t 1
ozguroglu, m 1
pang, hhm 1
pang, q 1
park, ys 1
poon, mcm 1
ryu, m-h 1
samaranayake, lp 1
seneviratne, cj 1
seong, j 1
shacham-shumueli, e 1
sham, mm 1
sham, pc 1
shaw, m 1
shi, j 1
shitara, k 1
shum, bcy 1
sin, j 1
sin, km 1
siu, swk 1
soong, is 1
spaander, mcw 1
sriuranpong, v 1
sudoyo, aw 1
sze, ck 1
szeto, mh 1
tang, sm 1
tang, y 1
tao, l 1
taw, btb 1
teh, cs 1
tin, pc 1
tong, dkh 1
tsang, hk 1
tsang, j 1
tsang, js 1
tsang, khk 1
tsang, rky 1
tsang, s 1
tsang, skc 1
tsang, thf 1
tse, r 1
tse, rp 1
tse, t 1
tung, y 1
vaid, ak 1
valkema, r 1
van der gaast, a 1
van der wilk, bj 1
van lanschot, jjb 1
verhoeft, k 1
verhoeft, kr 1
wan, ky 1
wang, jy 1
wang, y 1
wen, j 1
wijnhoven, bpl 1
wong, cly 1
wong, fcs 1
wong, gkw 1
wong, h 1
wong, iwc 1
wong, iyh 1
wong, j 1
wong, jc 1
wong, kh 1
wong, lyc 1
wong, mcs 1
wong, mp 1
wong, ssw 1
wong, sy 1
wong, whj 1
xie, c 1
xu, n 1
xu, xp 1
yang, h 1
yang, li 1
yang, y 1
yau, t 1
yau, tk 1
yeung, csy 1
yeung, rmw 1
yeung, sy 1
ying, ach 1
yoon, sm 1
yu, z 1
yu, zt 1
yuan, h 1
yuen, a 1
yuen, cm 1
yuen, st 1
zeng, zc 1
zhang, a 1
zhang, j 1
zhang, j 1
zhang, jy 1
zhang, rq 1
zhang, sz 1
zhang, x 1
zhang, ys 1
zheng, s 1
zhou, l 1
View More
Keywords in Publications
keywordsNo. of Authors
whole-exome sequencing 24
nasopharyngeal carcinoma 23
aged 15
advanced cancer 14
cancer susceptibility genes 13
early-age onset 13
gastric cancer 13
mst1r 13
apobec-mediated signature 12
nf-κb signaling 12
somatic mutation landscape 12
arhgap fusions 10
biobank 10
cancer center 10
cancer patient 10
cancer radiotherapy 10
chemoradiotherapy 10
drug screening 10
ebv genome 10
heterogeneity 10
intensity-modulated radiation therapy 10
organoid culture 10
rhoa mutations 10
transcriptome sequencing 10
leucocyte telomere length 9
medical sciences 9
neoadjuvant therapy 9
npc risk 9
plasma ebv dna 9
prognostic marker 9
survival 9
telomere biology 9
chemotherapy 8
circulating neoplastic cell 8
circulating tumor dna 8
liquid biopsy 8
oncology 8
recursive partitioning analysis 8
stage classification 8
survival prediction 8
adjuvant chemotherapy 7
adolescent 7
adult 7
cancer adjuvant therapy 7
cancer chemotherapy 7
cancer prognosis 7
cancer screening 7
cell-free dna 7
circulating tumor cells 7
ctc enumeration 7
esophageal cancer 7
evidence based medicine 7
longitudinal real-time monitoring 7
non-invasive biomarker 7
non-metastatic 7
oesophageal cancer 7
oesophageal squamous cell carcinoma 7
oesophagectomy 7
prognostic factors 7
radiotherapy 7
concurrent chemoradiotherapy 6
esophagectomy 6
metastatic 6
non-small cell lung cancer 6
palliative care 6
positron emission tomography 6
prognostic factor 6
aetiology 5
chinese 5
half-life clearance 5
her2+ breast cancer 5
her2-targeted therapy 5
immunotherapy 5
local clinical remission 5
metastatic brain tumours 5
metastatic colorectal cancer 5
metronomic 5
oral cyclophosphamide 5
palliative 5
plasma epstein–barr virus deoxyribonucleic acid 5
post-treatment plasma ebv dna 5
prognostication 5
radiation therapy 5
radiology and nuclear medicine 5
recurrent 5
surgery 5
systemic treatment 5
tyrosine kinase inhibitor 5
5-fluorouracil 4
cancer outcomes 4
cancer site-standardized relative survival 4
capecitabine 4
cetuximab 4
cisplatin 4
dynamic contrast enhanced 4
esophageal squamous cell carcinoma 4
global health 4
health economics 4
immune checkpoint inhibitor 4
intravoxel incoherent motion 4
magnetic resonance imaging 4
neoplasm metastasis 4
s-1 (combination) 4
squamous cell carcinoma 4
stomach neoplasms 4
target therapy 4
tumor staging 4
accuracy 3
active surveillance 3
brachytherapy 3
cervical esophageal cancer 3
cytology and histology 3
do-not-resuscitate 3
dysphagia 3
end of life 3
high dose rate endorectal brachytherapy 3
intensity modulated radiotherapy 3
international atomic energy agency (iaea) 3
laryngeal preservation 3
low-middle income countries 3
medically inoperable 3
nasopharyngeal cancer (npc) 3
nasopharyngectomy 3
neoadjuvant chemoradiotherapy 3
oncology medical sciences 3
radiology and nuclear medicine pharmacy and pharmacology biology 3
radiotherapy access 3
rectal brachytherapy 3
rectal cancer 3
standard of care 3
targeted therapy 3
toxicity 3
adenocarcinoma 2
bmp antagonist 2
breast cancer 2
cancer 2
cancer incidence 2
cancer mortality 2
cancer survival 2
chinese herbal medicine 2
communication 2
docetaxel 2
esophageal 2
esophageal adenocarcinoma 2
esophagogastric 2
esophagogastric junction adenocarcinoma 2
gastric cancer progression 2
hepatotoxicity 2
hong kong 2
jnk inhibition 2
liver toxicity 2
neoadjuvant 2
perioperative 2
preoperative 2
refractory 2
regorafenib 2
sostdc1 2
terminal care 2
trifluridine/tipiracil (tas-102) 2
chemotherapy, adjuvant 1
colorectal neoplasms 1
induction chemotherapy 1
oxaliplatin 1
receptor, epidermal growth factor 1
rectal neoplasms 1
vascular epidermal growth factor 1
View More
Keywords in Grants
keywordsNo. of Investigators
esophageal cancer, circulating tumor cell, biomarker, metastasis, tumor evolution, drug resistance 8
11c-acetate, pet-ct, tumour, stereotactic body, liver transplantation, hepatocellular carcinoma 7
cfi-400945, gastroesophageal junction, adenocarcinoma, prior therapy, platinum and fluoropyrimidine 7
radiosensitivity, predictive, biomarker, radiotherapy, de-intensification, nasopharyngeal 7
colorectal cancer, liver metastasis, resectability, circulating tumor cells, next generation sequencing 6
elucidating, tumor heterogeneity and molecular evolution, metastatic, gastrointestinal tract cancers, personalized medicine 6
pd-l1-positive, tumour, predicting, chemoradiation, nasopharyngeal, carcinoma 6
improving, access, chemotherapy, locorgionally, advanced, esophageal 5
metastatic colorecal, liver resection, circulating tumor cells, clinical risk score 5
bioinformatics, cancer immunotherapy, gastrointestinal tract, pd-1/pdl-1 inhibition, cancer genomics, whole-exome sequencing 4
colorectal cancer, prognostic biomarker, next generation sequencing, metastatic relapse, molecular subtypes, liquid biopsies 4
cost-effectiveness, metastatic colorectal, ras, anti-egfr monoclonal, first-line therapy 4
nasopharyngeal carcinoma, tumour heterogeneity, clonal evolution, whole-exome sequencing 4
nasopharyngeal, immunotherapy, immunopathology, epstein-barr virus, recurrent/metastitic 4
nasopharyngeal, individual dietary, intensity modulated, nurition 4
non-invasive, metastatic, colorectal, next-generation, tumor, cells 4
ebv, dna testing, nasopharyngeal, carcinoma 3
granulocyte-colony, neutropenia, palliative, chemotherapy, metastatic, cancer 3
View More
Disciplines in Grants
DisciplinesNo. of Investigators
others - medicine, dentistry and health 25
cancer,genomic biology 11
View More